ECSP034702A - COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS - Google Patents
COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONSInfo
- Publication number
- ECSP034702A ECSP034702A ECSP034702A ECSP034702A EC SP034702 A ECSP034702 A EC SP034702A EC SP034702 A ECSP034702 A EC SP034702A EC SP034702 A ECSP034702 A EC SP034702A
- Authority
- EC
- Ecuador
- Prior art keywords
- peroxismal
- treatment
- inhibitor
- combinations
- deactivator
- Prior art date
Links
- 229930182558 Sterol Natural products 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 title abstract 2
- 230000004913 activation Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000035755 proliferation Effects 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000002792 vascular Effects 0.000 title abstract 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 150000003432 sterols Chemical class 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 108091006084 receptor activators Proteins 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona composiciones, combinaciones terapéuticas y métodos que incluyen: A) por lo menos un activador del receptor de activación de proliferación peroxismal; y (B) por lo menos un inhibidor de absorción de esterol de azetidinona sustituida o de B-lactama sustituida que puede ser útil en el tratamiento de condiciones vasculares, diabetes, obesidad y reducción de los niveles plasmáticos de esteroles.The present invention provides compositions, therapeutic combinations and methods that include: A) at least one peroxismal proliferation activation receptor activator; and (B) at least one substituted azetidinone or substituted B-lactam sterol absorption inhibitor that may be useful in the treatment of vascular conditions, diabetes, obesity and reduction of plasma sterile levels.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26439601P | 2001-01-26 | 2001-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034702A true ECSP034702A (en) | 2003-09-24 |
Family
ID=34572580
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034704 ECSP034704A (en) | 2001-01-26 | 2003-07-24 | INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES |
| ECSP034702 ECSP034702A (en) | 2001-01-26 | 2003-07-24 | COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS |
| ECSP034703 ECSP034703A (en) | 2001-01-26 | 2003-07-24 | COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034704 ECSP034704A (en) | 2001-01-26 | 2003-07-24 | INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034703 ECSP034703A (en) | 2001-01-26 | 2003-07-24 | COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS |
Country Status (3)
| Country | Link |
|---|---|
| CN (2) | CN101297969B (en) |
| EC (3) | ECSP034704A (en) |
| ZA (2) | ZA200305692B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103086938A (en) * | 2011-10-28 | 2013-05-08 | 沈阳药科大学 | Ezetimibe synthesis method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3300B (en) * | 1992-12-23 | 1995-06-26 | Schering Corp | Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor |
| EP0766667A1 (en) * | 1994-06-20 | 1997-04-09 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
| AU779264B2 (en) * | 1998-12-23 | 2005-01-13 | G.D. Searle Llc | Combinations for cardiovascular indications |
-
2002
- 2002-01-25 CN CN2008100956414A patent/CN101297969B/en not_active Expired - Lifetime
- 2002-01-25 CN CN2006101262331A patent/CN1915429B/en not_active Expired - Lifetime
-
2003
- 2003-07-23 ZA ZA200305692A patent/ZA200305692B/en unknown
- 2003-07-23 ZA ZA200305694A patent/ZA200305694B/en unknown
- 2003-07-24 EC ECSP034704 patent/ECSP034704A/en unknown
- 2003-07-24 EC ECSP034702 patent/ECSP034702A/en unknown
- 2003-07-24 EC ECSP034703 patent/ECSP034703A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200305694B (en) | 2004-10-25 |
| CN1915429A (en) | 2007-02-21 |
| CN1915429B (en) | 2010-12-15 |
| CN101297969B (en) | 2011-03-09 |
| ZA200305692B (en) | 2004-10-25 |
| ECSP034704A (en) | 2003-09-24 |
| CN101297969A (en) | 2008-11-05 |
| ECSP034703A (en) | 2003-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP11004702A (en) | COMBINATIONS DEACTIVATOR (S) OF THE PEROXISMAL PROLIFERATION ACTIVATION RECEIVER (PPAR) AND STEROL ABSORPTION INHIBITOR (ES) AND TREATMENTS FOR VASCULAR INDICATIONS | |
| ECSP074704A (en) | INHIBITOR COMBINATIONS (S) OF STEROL ABSORPTION WITH BLOOD MODIFIER (S) TO TREAT VASCULAR TABLES | |
| MXPA03006631A (en) | Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications. | |
| CY1110894T1 (en) | METHODS FOR THE TREATMENT OR PREVENTION OF VASCULAR INFLAMMATION USING STEROLIS ABSORBTOR (S) | |
| CY1107174T1 (en) | ASPIRINE RELIEF COMBINATIONS FOR VASCULAR THERAPY | |
| CY1106149T1 (en) | THE USE OF SUBSTITUTED AZETIDINONE COMPOUNDS FOR THE TREATMENT OF SITOSTEPOLEMIA | |
| WO2005046797A3 (en) | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions | |
| ECSP066635A (en) | USEFUL KINOLINES IN THE TREATMENT OF CARDIOVASCULAR DISEASES | |
| MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| WO2002058685A3 (en) | Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications | |
| MY137620A (en) | Therapeutic treatment | |
| EA200702212A1 (en) | METHOD OF TREATMENT OR PREVENTION OF BONE DESTRUCTION OR OSTEOPOROSIS | |
| MXPA03010406A (en) | Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg. | |
| ECSP034702A (en) | COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS | |
| EP1879591B8 (en) | Use of azapaullones for preventing and treating pancreatic autoimmune disorders | |
| BR0008603A (en) | Copd treatment method | |
| UA85187C2 (en) | 2-aminobenzoyl derivatives | |
| BR0317491A (en) | Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia. | |
| EP1864680A3 (en) | Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications | |
| DE60110468D1 (en) | CHEMICAL COMPOUNDS | |
| PL1819354T3 (en) | Methods and compounds for treating diabetes | |
| BG105832A (en) | Inner fixing part for metal osteosynthesis | |
| ECSP066623A (en) | BENCIMIDAZOL-, BENZTRIAZOL-, AND BENCIMIDAZOLONA-O-GLUCOSIDS REPLACED | |
| DOP2002000450A (en) | PIPERIDINE SHIELDED DERIVATIVES AS MELANOCORTINA-4 RECEIVER AGONISTS | |
| UA87851C2 (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |